See more : PharmaEssentia Corporation (6446.TW) Income Statement Analysis – Financial Results
Complete financial analysis of Nissan Securities Group Co., Ltd. (8705.T) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Nissan Securities Group Co., Ltd., a leading company in the Financial – Capital Markets industry within the Financial Services sector.
- ZTO Express (Cayman) Inc. (ZTO) Income Statement Analysis – Financial Results
- ON Semiconductor Corporation (0KC4.L) Income Statement Analysis – Financial Results
- Hoshizaki Corporation (HSHZY) Income Statement Analysis – Financial Results
- KSB SE & Co. KGaA (KSB.DE) Income Statement Analysis – Financial Results
- Jiangmen Kanhoo Industry Co., Ltd (300340.SZ) Income Statement Analysis – Financial Results
Nissan Securities Group Co., Ltd. (8705.T)
Industry: Financial - Capital Markets
Sector: Financial Services
Website: https://www.nissansec-g.co.jp
About Nissan Securities Group Co., Ltd.
Nissan Securities Group Co., Ltd., together with its subsidiaries, engages in the financial instrument brokerage and commodity future trading businesses in Japan and internationally. The company is also involved in the self-trading; money lending; and debt collection and consolidation businesses. In addition, it provides system operation and maintenance, and data center maintenance and management services; and information gathering, and business and system support services. The company was formerly known as Okato Nissan Secs Holdings Inc. and changed its name to Nissan Securities Group Co., Ltd. in July 2022. Nissan Securities Group Co., Ltd. was founded in 1948 and is headquartered in Tokyo, Japan.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 7.74B | 6.61B | 7.20B | 7.74B | 2.85B |
| Cost of Revenue | 45.12M | 47.21M | 43.83M | 74.55M | 23.71M |
| Gross Profit | 7.70B | 6.56B | 7.15B | 7.66B | 2.83B |
| Gross Profit Ratio | 99.42% | 99.29% | 99.39% | 99.04% | 99.17% |
| Research & Development | 0.00 | 0.05 | 0.06 | 0.22 | 0.04 |
| General & Administrative | 2.44B | 2.10B | 2.13B | 2.02B | 118.00M |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 52.66M |
| SG&A | 2.44B | 2.10B | 2.13B | 2.02B | 52.66M |
| Other Expenses | 4.35B | 1.59M | 29.90M | 13.97M | 5.82M |
| Operating Expenses | 6.79B | 6.31B | 7.37B | 7.16B | 2.76B |
| Cost & Expenses | 6.84B | 6.36B | 7.41B | 7.24B | 2.76B |
| Interest Income | 27.91M | 10.10M | 1.10M | 3.53M | 1.86M |
| Interest Expense | 405.00K | 0.00 | 406.00K | 466.00K | 4.69M |
| Depreciation & Amortization | 250.23M | 258.98M | 325.48M | 316.60M | 18.00M |
| EBITDA | 1.08B | 694.01M | 1.16B | 989.46M | -204.00M |
| EBITDA Ratio | 13.93% | 9.16% | 3.90% | 12.54% | -7.16% |
| Operating Income | 904.02M | 274.72M | -163.95M | 580.82M | -222.00M |
| Operating Income Ratio | 11.68% | 4.16% | -2.28% | 7.51% | -7.79% |
| Total Other Income/Expenses | -75.70M | 90.00M | -369.86M | 1.17B | 4.91M |
| Income Before Tax | 828.31M | 364.71M | 464.36M | 1.75B | 112.00M |
| Income Before Tax Ratio | 10.70% | 5.52% | 6.45% | 22.66% | 3.93% |
| Income Tax Expense | 275.14M | 106.20M | -71.39M | 165.70M | 25.00M |
| Net Income | 553.18M | 258.51M | 535.76M | 1.59B | 89.00M |
| Net Income Ratio | 7.14% | 3.91% | 7.44% | 20.52% | 3.12% |
| EPS | 9.80 | 4.47 | 9.21 | 30.63 | 8.15 |
| EPS Diluted | 9.73 | 4.47 | 9.18 | 30.19 | 8.11 |
| Weighted Avg Shares Out | 56.46M | 57.75M | 58.14M | 51.83M | 10.92M |
| Weighted Avg Shares Out (Dil) | 56.85M | 57.75M | 58.36M | 52.60M | 10.97M |
Source: https://incomestatements.info
Category: Stock Reports